Helsel Dave
- SEC CIK
- 0001543753
No open-market purchases or sales filed in the past year.
Current role at each company
- ANGO Angiodynamics IncSVP Global Operations and R&Das of Sep 21, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Helsel Dave as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2023 (view filing) | Jan 31 | 1 day | Helsel DaveSVP Global Operations and R&D | SSale | −4.63K | $12.95 | −$60.0K | −19.4%19.2K after | |
| Aug 1, 2022 (view filing) | Jul 29 | 3 days | Helsel DaveSVP Global Operations and R&D | SSale | −5.00K | $22.44 | −$112.2K | −17.3%23.8K after | |
| May 2, 2022 (view filing) | Apr 28 | 4 days | Helsel DaveSVP Global Operations and R&D | SSale | −3.51K | $22.44 | −$78.8K | −13.3%22.9K after | |
| Oct 21, 2021 (view filing) | Oct 20 | 1 day | Helsel DaveSVP Global Operations and R&D | SSale | −3.49K | $27.97 | −$97.7K | −11.7%26.4K after |